The latter would explain, why UCP2 is often reported to be up-regulated in a range of neurodegenerative and ischemic disease such as multiple sclerosis, seizure, stroke, brain trauma, and ischemia [49]–[56]. This evidence concerns the gene UCP2 and ischemic disease.